Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.932
-$0.018-1.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.27M | -11.64M | -11.64M | 3.82M | -8.69M |
| Total Depreciation and Amortization | 173.00K | 92.00K | 92.00K | 238.00K | 164.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 727.00K | 2.53M | 2.53M | 896.00K | 1.23M |
| Change in Net Operating Assets | -587.00K | 1.20M | 1.20M | -8.95M | 6.71M |
| Cash from Operations | -9.96M | -7.82M | -7.82M | -3.99M | -591.00K |
| Capital Expenditure | -81.00K | -157.00K | -157.00K | -218.00K | -- |
| Sale of Property, Plant, and Equipment | 2.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.56M | -7.71M | -7.71M | 6.36M | 9.25M |
| Cash from Investing | -20.64M | -7.86M | -7.86M | 6.14M | 9.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 74.00K | 74.00K | -74.00K | -- |
| Issuance of Common Stock | 2.00K | 62.50K | 62.50K | 51.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.00K | 136.50K | 136.50K | -23.00K | -- |
| Foreign Exchange rate Adjustments | 75.00K | -252.50K | -252.50K | -45.00K | -221.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.52M | -15.80M | -15.80M | 2.08M | 8.44M |